Women’s Health

Children of mothers with untreated gestational diabetes mellitus are at risk of insulin resistance and impairment in glucose metabolism.

Optimism correlated with lower incidence of type 2 in postmenopausal women.

Trial examines differences in glycemic control and quality of life when using different insulin delivery methods.

Diabetes in Control is pleased to bring you an exclusive interview with Dr. Andrea Dunaif, the Lillian and Henry M. Stratton Professor of Molecular Medicine and Chief of the J. Lester Gabrilove Division of Endocrinology, Diabetes and Bone Disease at the Icahn School of Medicine at Mount Sinai, New York, NY. Dr. Dunaif is an internationally recognized expert in endocrinology and women’s health. Her research on polycystic ovary syndrome (PCOS), the most common hormonal disorder of reproductive-age women, has shown that it is a leading risk factor for type 2 diabetes mellitus. Further, this research has revolutionized the treatment of PCOS with insulin-sensitizing drugs.

Researchers find every 0.1% increase in HbA1c above 5.1% increases diagnosis risk by 22%.

Andrea Dunaif, M.D., is the Lillian and Henry M. Stratton Professor of Molecular Medicine and Chief of the J. Lester Gabrilove Division of Endocrinology, Diabetes and Bone Disease at the Icahn School of Medicine at Mount Sinai, New York, NY. Dr. Dunaif is an internationally recognized expert in endocrinology and women’s health. Her research on polycystic ovary syndrome (PCOS), the most common hormonal disorder of reproductive-age women, has shown that it is a leading risk factor for type 2 diabetes mellitus. Further, this research has revolutionized the treatment of PCOS with insulin sensitizing drugs.

In this Exclusive Interview transcript, Andrea Dunaif talks with Diabetes in Control Medical Editor Joy Pape during the ADA 2018 convention in Orlando about the relation of Polycystic Ovarian Syndrome to diabetes, its causes, diagnosis, and even the inaccuracy of the name.

In this Exclusive Interview, Andrea Dunaif talks with Diabetes in Control Medical Editor Joy Pape during the ADA 2018 convention in Orlando about the causes, diagnosis, and even the inaccuracy of the name Polycystic Ovarian Syndrome (PCOS), as well as its relation to diabetes.

In part 1 of this Exclusive Interview, Andrea Dunaif talks with Diabetes in Control Medical Editor Joy Pape about the importance of understanding PCOS and its associated risks.

In part 2 of this Exclusive Interview, Andrea Dunaif talks with Diabetes in Control Medical Editor Joy Pape about the PCOS-related diabetes.